SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-17-074069
Filing Date
2017-12-19
Accepted
2017-12-19 17:02:50
Documents
2
Group Members
NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a17-27581_1sc13ga.htm SC 13G/A 82147
2 EX-99 a17-27581_1ex99.htm EX-99 13463
  Complete submission text file 0001104659-17-074069.txt   97236
Mailing Address LICHTSTRASSE 35 BASEL V8 CH 4056
Business Address LICHTSTRASSE 35 BASEL V8 CH 4056 01141613241111
NOVARTIS AG (Filed by) CIK: 0001114448 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Subject) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88812 | Film No.: 171264696
SIC: 2834 Pharmaceutical Preparations